Blueprints of Life: Unlocking the Power of Modern Biotechnology
Articles

The effectiveness of the Rotigotine Transdermal Patch in Parkinson’s Disease along with Clinical Cases

Souradeep Banerjee
Department of Biotechnology, School of Life Sciences, Swami Vivekananda University, Barrackpore Kolkata 700121
Tuhin Mukherjee
Department of Biotechnology, School of Life Sciences, Swami Vivekananda University, Barrackpore Kolkata 700121
Tanya Das
Department of Biotechnology, School of Life Sciences, Swami Vivekananda University, Barrackpore Kolkata 700121
Mayisha Sultana
Department of Biotechnology, School of Life Sciences, Swami Vivekananda University, Barrackpore Kolkata 700121
Satadru Ghosh
Department of Biotechnology, School of Life Sciences, Swami Vivekananda University, Barrackpore Kolkata 700121
Suranjana Sarkar
Department of Microbiology, School of Life Sciences, Swami Vivekananda University, Barrackpore, Kolkata 700121
Priyajit Banerjee
Corresponding Author at:Laboratory of Drug Discovery and Protein Engineering, School of Life Sciences, Swami Vivekananda University, Barrackpore, Pin- 700121, West Bengal, India.

Published 2025-12-03

Keywords

  • levodopa,
  • monotherapy,
  • receptors,
  • placebo,
  • rotigotine

How to Cite

Banerjee, Souradeep, et al. “The Effectiveness of the Rotigotine Transdermal Patch in Parkinson’s Disease Along With Clinical Cases”. Swami Vivekananda University Press, Dec. 2025, pp. 238-52, https://swamivivekanandauniversitypress.com/index.php/svup/article/view/182.

Abstract

Rotigotine, a non-ergot dopamine receptor agonist targeting D3/D2/D1 receptors, is administered through a transdermal delivery system which has been studied for managing idiopathic Parkinson’s disease.

DOI - https://doi.org/10.65525/SVUP.9788198800473.2025.238-252